CHRONIC MYELOMONOCYTIC LEUKEMIA-2
Clinical trials for CHRONIC MYELOMONOCYTIC LEUKEMIA-2 explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOMONOCYTIC LEUKEMIA-2 trials appear
Sign up with your email to follow new studies for CHRONIC MYELOMONOCYTIC LEUKEMIA-2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat leukemias: first human trial begins
Disease control Recruiting nowThis early-stage study tests a new drug called STX-0712 in people with advanced types of leukemia (CMML or AML) that have not responded to other treatments. The main goals are to find a safe dose and check for side effects. About 105 adults will take part in this first-in-human t…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA-2
Phase: PHASE1 • Sponsor: Solu Therapeutics, Inc • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New pill shows promise for Hard-to-Treat blood cancers
Disease control Recruiting nowThis study tests a new daily pill, LP-118, in up to 100 people with blood cancers that have come back or not responded to treatment. The main goal is to find the safest dose and see how the drug works in the body. Early results will also hint at whether it can shrink tumors or sl…
Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA-2
Phase: PHASE1 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated May 06, 2026 16:03 UTC